2-Butyl-3-(p-tolyl)quinuclidine (BTQ) is a stimulant DRI. It is one of a number of substituted quinuclidine derivatives developed as potential medications for the treatment of cocaine abuse, and produces similar effects to cocaine in animal studies, although milder and longer-lasting.

Property Value
dbo:abstract
  • 2-Butyl-3-(p-tolyl)quinuclidine (BTQ) is a stimulant DRI. It is one of a number of substituted quinuclidine derivatives developed as potential medications for the treatment of cocaine abuse, and produces similar effects to cocaine in animal studies, although milder and longer-lasting. (en)
dbo:thumbnail
dbo:wikiPageEditLink
dbo:wikiPageExtracted
  • 2019-06-08 16:12:31Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 17682266 (xsd:integer)
dbo:wikiPageLength
  • 3098 (xsd:integer)
dbo:wikiPageModified
  • 2019-06-08 08:06:46Z (xsd:date)
dbo:wikiPageOutDegree
  • 8 (xsd:integer)
dbo:wikiPageRevisionID
  • 900889846 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • 2-Butyl-3-(p-tolyl)quinuclidine (BTQ) is a stimulant DRI. It is one of a number of substituted quinuclidine derivatives developed as potential medications for the treatment of cocaine abuse, and produces similar effects to cocaine in animal studies, although milder and longer-lasting. (en)
rdfs:label
  • Butyltolylquinuclidine (en)
owl:sameAs
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is foaf:primaryTopic of